High-Throughput Drug Screening for Alzheimer’s Disease Using Three-Dimensional Human Neural Culture Systems

2020

Alzheimer’s disease (AD) has become a significant public health problem, but there is currently no cure for the disease. We pioneered a novel three-dimensional (3D) Alzheimer’s in a Dish model that can revolutionize AD drug screening. This ongoing project will identify and validate novel AD drug candidates using our 3D AD cellular model as a drug screening platform. We will continue to validate and identify AD drug candidates from natural products and microglial-modulating drugs in this period. This year, we will start a pilot drug screening to identify neuroprotective drugs against pathogenic amyloid accumulation and oxidative stress. This study’s goal is to find novel AD drug candidates directly applicable to human clinical trials.

3DDS Doo Yeon Kim Drug Discovery Drug Screening Projects Luisa Quinti

Related Content:

Exploring Novel Drug Candidates for Alzheimer’s Disease Through Integrative Pathway Analysis and Validation in 3D Cellular Models Doo Yeon Kim Luisa Quinti 2024-02-01 Development of Small Molecule Inhibitors of Cholesterol 25-hydroxylase Anil Cashikar Bahaa Elgendy 2024-02-01 Validation and Characterization of Compounds Modulating Neuroinflammation and Amyloid Beta Uptake in Microglial Cells Ana Griciuc Luisa Quinti 2023-10-25 Identification and Development of CD33 Inhibitors and Pre-RNA Splicing Modulators Subhash Sinha 2023-10-25 Alzheimer’s Disease Drug Discovery and Development Consortium: Blocking Synaptotoxicity in Alzheimer’s Three-Dimensional Models Weiming Xia 2022-02-17 Alzheimer’s Disease Drug Discovery and Development Consortium: Uncovering the Molecular Mechanism of Selected Drug Candidates Derived from Systematic Alzheimer’s Drug Repositioning Stephen T.C. Wong 2022-02-17 Stimulating Synaptic Proteasome Activity for the Treatment of Alzheimer’s Disease Hermann Steller 2022-02-15 Alzheimer’s Disease Drug Discovery and Development Consortium: High-Throughput Drug Screening for Alzheimer’s Disease Using Three-Dimensional Human Neural Culture Systems Doo Yeon Kim Luisa Quinti 2022-02-14